BMJ Open · 2021 · 13 citations · 12 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceClinical PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyBacteremia ManagementCarbapenem ResistanceTargeted Antimicrobial TherapyCarbapenem-resistant EnterobacteralesCephalosporin TherapyEnterobacterales InfectionsEnterobacterales ResistanceLong-term Clinical SuccessPrimary Outcome AnalysisTargeted Intravenous TherapyTreatment Of Bacterial Resistance
INTRODUCTION: (3GCR-E). Temocillin is a suitable candidate, but comparative randomised studies are lacking. The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due to 3GCR-E. METHODS AND ANALYSIS: Multicentre, open-label, randomised, controlled, pragmatic phase 3 trial. Patients with bacteraemia due to 3GCR-E will be randomised to receive intravenously temocillin (2 g three times a day) or carbapenem (meropenem 1 g three times a day or ertapenem 1 g once daily). The primary endpoint will be clinical success 7-10 days after end of treatment with no recurrence or death at day 28. Adverse events will be collected; serum levels of temocillin will be investigated in a subset of patients. For a 10% non-inferiority margin, 334 patients will be included (167 in each study arm). For the primary analysis, the absolute difference with one-sided 95% CI in the proportion of patients reaching the primary endpoint will be compared in the modified intention-to-treat population. ETHICS AND DISSEMINATION: The study started after approval of the Spanish Regulatory Agency and the reference institutional review board. Data will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT04478721.
12
Alessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras et al. · The Lancet Infectious Diseases · 2018 · 3K citations · Full text
Veterinary Medicine, Health Sciences, Infectious Diseases +17
New England Journal of Medicine · 2016 · 1.4K citations · Full text
Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text
Indran Balakrishnan, Fatih M. Awad-El-Kariem, Adnan Aali et al. · Journal of Antimicrobial Chemotherapy · 2011 · 109 citations · Full text